Bicocca Open Archive

Logo unimib boa
MASSERINI, MASSIMO ERNESTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.626
EU - Europa 6.652
AS - Asia 2.316
SA - Sud America 28
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 22
Totale 21.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.289
DE - Germania 1.250
CN - Cina 1.199
IT - Italia 1.125
SE - Svezia 1.099
IE - Irlanda 867
UA - Ucraina 661
GB - Regno Unito 414
SG - Singapore 389
RU - Federazione Russa 361
CA - Canada 327
HK - Hong Kong 252
FI - Finlandia 223
IN - India 171
PL - Polonia 125
FR - Francia 115
VN - Vietnam 113
DK - Danimarca 84
AT - Austria 83
BE - Belgio 68
NL - Olanda 47
TR - Turchia 38
IR - Iran 37
BG - Bulgaria 36
EU - Europa 23
PT - Portogallo 21
AU - Australia 20
JP - Giappone 20
ES - Italia 18
ID - Indonesia 18
BR - Brasile 17
KR - Corea 17
CH - Svizzera 15
TW - Taiwan 14
CZ - Repubblica Ceca 12
RO - Romania 12
ZA - Sudafrica 12
IL - Israele 10
MX - Messico 9
CL - Cile 7
HU - Ungheria 6
IQ - Iraq 5
MY - Malesia 5
TH - Thailandia 5
EG - Egitto 4
GR - Grecia 4
PK - Pakistan 4
AR - Argentina 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
MU - Mauritius 3
CI - Costa d'Avorio 2
LB - Libano 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CY - Cipro 1
EC - Ecuador 1
HN - Honduras 1
JO - Giordania 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
SC - Seychelles 1
YE - Yemen 1
Totale 21.693
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.237
Woodbridge 1.577
Chandler 1.058
Houston 864
Dublin 843
Fairfield 832
Jacksonville 751
Frankfurt am Main 702
Wilmington 610
Ashburn 607
Dearborn 596
Milan 520
Seattle 383
New York 308
Cambridge 293
Princeton 278
Singapore 265
Hong Kong 233
Nanjing 221
Beijing 171
Shanghai 158
Lachine 127
Kraków 114
Lawrence 110
Altamura 103
Toronto 94
Helsinki 88
Nanchang 82
Vienna 82
Guangzhou 70
Boardman 68
Hangzhou 68
San Diego 66
Ottawa 64
Brussels 62
Dong Ket 55
Andover 51
Changsha 49
Fremont 49
Tianjin 44
Wayne 43
Santa Clara 42
Shenyang 42
Falls Church 38
Hebei 36
Jiaxing 36
Plovdiv 36
Jinan 35
Mountain View 31
Nürnberg 31
Zhengzhou 28
Auburn Hills 27
Kunming 26
Norwalk 24
Rome 24
Grafing 21
Ningbo 21
Dallas 20
Huizen 20
Redmond 20
Pune 19
Chicago 16
London 16
Los Angeles 16
Montréal 16
Hefei 15
Edmonton 14
Jakarta 14
Taizhou 14
Lecco 13
New Delhi 13
Detroit 12
San Mateo 12
Monmouth Junction 11
Washington 11
Ahmedabad 10
Amsterdam 10
Fuzhou 10
Leawood 10
Segrate 10
Taipei 10
University Park 10
Zanjan 10
Brno 8
Copenhagen 8
Kiev 8
Munich 8
Palermo 8
Porto 8
Verona 8
Cusano Milanino 7
Duncan 7
Pavia 7
Philadelphia 7
Rajsamand 7
São Paulo 7
Tappahannock 7
Cape Town 6
Central 6
Central District 6
Totale 15.969
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 450
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 327
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 313
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 312
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 310
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 278
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 274
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 255
Nanomedicine for the treatment of Alzheimer's disease 252
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 248
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 245
Morphogenic effect of common solvent in the self-assembly behavior of amphiphilic PEO-b-PLA 244
Versatile and Efficient Targeting Using a Single Nanoparticulate Platform and its Application to Cancer and Alzheimer's Disease 238
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 235
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 230
TrkA pathway activation induced by amyloid-beta (Abeta) 227
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 227
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 225
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 224
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 223
Curcumin derivatives as new ligands of Aβ peptides 221
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 214
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 211
Enhanced brain targeting of engineered solid lipid nanoparticles 211
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 202
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 196
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 195
Developmental changes in the protein composition of sphingolipid- and cholesterol-enriched membrane domains of rat cerebellar granule cells 194
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 193
Inhibition of murine leukemia (WEHI-3B and L1210) proliferation by cholera toxin B subunit 191
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 190
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 189
Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cells 184
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 184
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 184
Interactions of proteins with ganglioside-enriched microdomains on the membrane: the lateral phase separation of molecular species of GD1a ganglioside, having homogeneous long-chain base composition, is recognized by Vibrio cholerae sialidase 183
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model 183
Effect of modified collagen on amyloid beta peptide aggregation 183
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds 183
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 182
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 181
Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor 180
Pin1: a new outlook in Alzheimer's disease 178
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 177
Role of lipid rafts and GM1 in the segregation and processing of Prion Protein 174
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 166
Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin 166
Abnormal cross-talk between mutant presenilin 1 (I143T, G384A) and glycosphingolipid biosynthesis 166
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 166
Ceramides and sphingomyelinases in senile plaques 165
ALCOHOL AND NEURAL LIPIDS 163
Two tail-anchored protein variants, differing in transmembrane domain length and intracellular sorting, interact differently with lipids 162
Pin1 affects Tau phosphorylation in response to Abeta oligomers 162
Age-related changes in the ceramide composition of the major gangliosides present in rat brain subcellular fractions enriched in plasma membranes of neuronal and myelin origin 162
mApoE-Functionalized Nanoliposomes Delivering Doxorubicin and Ultrasmall Superparamagnetic Iron Oxide to Glioblastoma Cells Characterized by TEM and Confocal Microscopy 162
Dependence of rat liver CMP-N-acetylneuraminate:GM1 sialyltransferase (SAT IV) activity on the ceramide composition of GM1 ganglioside 160
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 160
Enhanced brain targeting of engineered solid lipid nanoparticles 160
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 159
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 158
Detection and Characterization of Different Brain-Derived Subpopulations of Plasma Exosomes by Surface Plasmon Resonance Imaging 158
Role of phosphatidylethanol in membranes. Effects on membrane fluidity, tolerance to ethanol, and activity of membrane-bound enzymes 157
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 157
A surveillance system for early-stage diagnosis of endogenous diseases by swarms of nanobots 155
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 155
A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface 154
Thermotropic behavior of fatty acid ethyl esters in phospholipid liposomes 154
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 154
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 154
Nanotechnology for neurodegenerative disorders 153
Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients 150
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 149
Ischemic conditions and β-secretase activation: The impact of membrane cholesterol enrichment as triggering factor in rat brain endothelial cells 147
Methyl-β-cyclodextrin treatment affects the thermotropic behaviour of membranes and detergent-resistant membrane fractions of cultured A431 cells 145
Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells 144
Early-Stage Diagnosis of Endogenous Diseases by Swarms of Nanobots: An Applicative Scenario 144
Influence of glycolipid oligosaccharide and long-chain base composition on the thermotropic properties of dipalmitoylphosphatidylcholine large unilamellar vesicles containing gangliosides 143
Changes in the composition of detergent-resistant membrane domains of cultured neurons following protein kinase C activation 143
Nanotechnology for neurodegenerative disorders 142
New tricyclic compounds, process for their manufacture and their use as ligands of beta-alyloid peptides 140
Preparation and use of liposomes for the study of sphingolipid segregation in membrane model systems 140
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 140
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 140
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 140
Effect of curcumin-associated and lipid ligand functionalised nanoliposomes on aggregation of the Alzheimer's Aβ peptide 139
Nanomedicine for the treatment of Alzheimer's disease 138
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications 137
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 136
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 134
Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 131
Self-assembled electrical biodetector based on reduced graphene oxide 130
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide 130
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease 130
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 130
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 130
Proteomics of plasma membrane microdomains 128
Implicazioni nutrizionali nella malattia di Alzheimer 128
Glycolipid-protein interaction in the mechanism of signal transduction: studies with a photoactivable ganglioside analogue 127
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 127
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 125
Totale 18.195
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.076
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.601 0 272 274 277 434 484 632 301 383 211 263 70
2020/20212.536 227 153 286 288 204 165 269 153 236 258 96 201
2021/20221.838 98 167 176 189 76 175 142 100 104 169 158 284
2022/20233.854 449 1.198 338 396 230 562 37 220 260 25 86 53
2023/20242.561 66 84 137 146 328 678 554 121 158 33 37 219
2024/2025658 244 414 0 0 0 0 0 0 0 0 0 0
Totale 22.379